Hospital
The Affiliated Hospital of Qingdao University青岛大学附属医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++ General list, 2023
-
Published research 16 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 19 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 青岛大学附属医院
- English name
- The Affiliated Hospital of Qingdao University
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Large language model treatment-pathway outputs based on structured clinical text in mid- and low rectal cancer: Concordance with multidisciplinary team decisions and features associated with discordance. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2026
- Retraction Notice to: “Mitigating Bias in Colorectal Cancer Research: Assessing the Limitations of the Cox Proportional Hazards Model and Considering Alternative Methods” Gastroenterology 2025;168:1197-1198. Gastroenterology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
-
Breast cancer
Published research
- A multimodal cross-temporal fusion system for complementary evaluation of neoadjuvant chemotherapy in breast cancer. European journal of radiology, 2026
- Tumor microenvironment-responsive self-assembling nanotherapeutics integrating chemo-, anti-angiogenic, and immunostimulatory therapy for triple-negative breast cancer. Biomaterials, 2027
4 more published studies
PubMed indexes 6 papers on this condition that name this hospital.
-
Lung cancer
Published research
- Nanocarrier-Mediated Nucleic Acid Therapy in Non-Small Cell Lung Cancer: Converging Delivery Barriers, Resistance Reversal, and Clinical Translation. Current gene therapy, 2026
PubMed indexes 1 paper on this condition that names this hospital.
-
Liver cancer
Published research
- Oncolytic virus-based immunotherapy for hepatocellular carcinoma: Strategies for enhanced efficacy and clinical application. Critical reviews in oncology/hematology, 2026
- SERBP1 promoter single nucleotide polymorphism (SNP) rs3762314: a genetic susceptibility biomarker promoting malignant phenotype in hepatocellular carcinoma. Biochemical and biophysical research communications, 2026
PubMed indexes 2 papers on this condition that name this hospital.
-
Cervical cancer
Published research
- Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review. Human vaccines & immunotherapeutics, 2026
PubMed indexes 1 paper on this condition that names this hospital.
-
Stomach cancer
Published research
- [Prehabilitation for high-risk gastric cancer populations: challenges, countermeasures, and the integrated whole-course pathway]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2026
- Solasonine inhibits growth of gastric cancer by targeting FTL-mediated ferroptosis. Bioorganic chemistry, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
-
Thyroid cancer
Published research
- Engrailed-1 Promotes Tumor Progression and Metastasis in Papillary Thyroid Cancer. Cancer biotherapy & radiopharmaceuticals, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24